Phase I study of the novel distamycin derivative tallimustine (FCE 24517).
Sessa C, Pagani O, Zurlo MG, de Jong J, Hofmann C, Lassus M, Marrari P, Strolin Benedetti M, Cavalli F.
Sessa C, et al. Among authors: zurlo mg.
Ann Oncol. 1994 Dec;5(10):901-7. doi: 10.1093/oxfordjournals.annonc.a058728.
Ann Oncol. 1994.
PMID: 7696161
Free article.
Clinical Trial.